Thermo Fisher Scientific Inc(TMO) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | S&P 500 | P/E | 32.58 | EPS (ttm) | 18.59 | Insider Own | 0.34% | Shs Outstand | 369.8M | Perf Week | 0.86% |
| Market Cap | 223.95B | Forward P/E | 22.1 | EPS next Y | 9.16% | Insider Trans | -7.97% | Shs Float | 368.5M | Perf Month | 1% |
| Enterprise Value | 262.55B | PEG | 2.25 | EPS next Q | 6.41 | Inst Own | 94.21% | Short Float | 1.29% | Perf Quarter | 22.59% |
| Income | 6.97B | P/S | 4.83 | EPS this Y | 9.79% | Inst Trans | -0.38% | Short Ratio | 2.33 | Perf Half Y | 21.12% |
| Sales | 46.34B | P/B | 4.25 | EPS next 5Y | 9.8% | ROA | 6.5% | Short Interest | 4.74M | Perf YTD | 4.53% |
| Book/sh | 142.47 | P/C | 54.96 | EPS past 3/5Y | 0.18% 2.11% | ROE | 13.51% | 52W High | -6.38% ($647.00) | Perf Year | 25.56% |
| Cash/sh | 11.02 | P/FCF | 30.6 | Sales past 3/5Y | -0.27% 6.7% | ROIC | 7.59% | 52W Low | 39.15% ($435.27) | Perf 3Y | 16.87% |
| Dividend Est. | $1.85 (0.31%) | EV/EBITDA | 22.28 | EPS Y/Y TTM | 7.47% | Gross Margin | 40.19% | Volatility(W/M) | 2.55% 2.41% | Perf 5Y | 6.49% |
| Dividend TTM | 1.8 | EV/Sales | 5.67 | Sales Y/Y TTM | 7.23% | Oper. Margin | 19.09% | ATR (14) | 15.81 | Perf 10Y | 321.55% |
| Dividend Ex-Date | 2026/9/15 | Quick Ratio | 1.18 | EPS Q/Q | 9.38% | Profit Margin | 15.04% | RSI (14) | 52.86 | Recom | 1.52 |
| Dividend Gr. 3/5Y | 12.75% 14.34% | Current Ratio | 1.55 | Sales Q/Q | 10.49% | SMA20 | -1.05% ($612.12) | Beta | 0.89 | Target Price | $653.56 |
| Payout | 9.7% | Debt/Eq | 0.81 | Earnings | 2026/7/23 | SMA50 | 5.43% ($574.49) | Rel Volume | 0.94 | Prev Close | $603.02 |
| Employees | 125000 | LT Debt/Eq | 0.74 | EPS/Sales Surpr. | 5.43% 2.46% | SMA200 | 12.92% ($536.39) | Avg Volume(3M) | 2.04M | Price | $605.69 |
| IPO | 1980/3/17 | Option/Short | Yes/Yes | Trades | 33441 | Volume | 1,915,749 | Change | 0.44% |
Company
TMO is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🔬 Thermo Fisher Scientific is a global leader in science solutions, supplying a broad range of products for life sciences research, diagnostics, bioprocessing, analytical instruments, and laboratory consumables. Founded in 2006 through the merger of Thermo Electron and Fisher Scientific, the company is headquartered in Waltham, Massachusetts, and is distinguished by its extensive product catalog and global distribution network.
Over the past 1 year, on the higher side
6% below its 1-year high.
Upcoming eventsD-days to next ex-dividend
Ex-dividend September 15
TMO makes money exceptionally well
19.09% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +9.8% this year.
Tap to view numbers
The price looks about right
Trading at 32.6 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 2 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Would have changed by +16.9% if bought 5 years ago.
Tap to view numbers
The dividend is on the small side
Pays 0.31% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 94.2%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
GDOC 0.05%
BEEZ 0.04%
TMED 0.04%
AGIQ 0.04%
HRTS 0.04%It is the largest in the industry
Based on market cap of $224B.
TMO $224B PER 32.6
DHR $144B PER 36.4
NTRA $48B PER -
IQV $42B PER 31.9
FAQ
What kind of company is TMO?
TMO belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is the market cap of TMO?
The market cap of TMO is approximately $224.0B, ranking 68 within its sector.
Does TMO pay dividends?
TMO has a dividend yield of approximately 0.31%, with an annual dividend of $1.85.
What is the P/E ratio of TMO?
TMO has a P/E ratio of approximately 32.6x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for TMO?
TMO has recorded a 52-week high of $647.00 and a low of $435.27.
